<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-ijms-21-03544">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Thanh Le</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Andreadakis</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gomez Roman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tollefsen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Saville</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mayhew</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>The COVID-19 vaccine development landscape</article-title>
  <source>Nat. Rev. Drug Discov.</source>
  <year>2020</year>
  <volume>19</volume>
  <fpage>305</fpage>
  <lpage>306</lpage>
  <pub-id pub-id-type="doi">10.1038/d41573-020-00073-5</pub-id>
  <pub-id pub-id-type="pmid">32273591</pub-id>
 </element-citation>
</ref>
